Membrane attack by complement. Assembly and biology of terminal complement complexes

Biomembranes: A Multi-Volume Treatise

Volumn 4, Issue C, 1996, Pages 123-149

  Shin, Moon L ^a   Rus, Horea G ^a   Niculescu, Florin I ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77957068516     PISSN: 18745342     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1874-5342(96)80007-9     Document Type: Review

References (104)

1. Adler S., Baker P., Johnson R.J., Ochi R., Pritzl P., and Couser W.G. Complement membrane attack complex stimulates production of reactive oxygen metabolites by cultured rat mesangial cells. J. Clin. Invest. 77 (1986) 762-767
2. Bhakdi S., and Tranum-Jensen J. Damage to mammalian cells by proteins that form transmembrane pores. Rev. Physiol. Biochem. Pharmacol. 107 (1987) 148-223
3. Biesecker G., Lavin L., Ziskind M., and Koffler D. Cutaneous localization of the membrane attack complex in discord and systemic lupus erythematosus. N. Engl. J. Med. 306 (1982) 264-270
4. Biesecker G., Katz S., and Koffler D. Renal localization of the membrane attack complex in systemic lupus erythematosus nephritis. J. Exp. Med. 159 (1981) 1779-1794
5. Bordet J. Les sérums hémolytiques, leurs antitoxines et les théories des sérums cytolytiques. Ann. Inst. Pasteur 14 (1900) 257-275
6. Carney D.F., Lang T.J., and Shin M.L. Multiple signal messengers generated by terminal complement complexes and their role in terminal complex elimination. J. Immunol. 145 (1990) 623-629
7. Carney D.F., Koski C.L., and Shin M.L. Elimination of terminal complement intermediates from the plasma membrane of nucleated cells: The rate of disappearance differs for cells carring C5b-7 or C5b-8 or a mixture of C5b-8 with a limited number of C5b-9. J. Immunol. 134 (1985) 1804-1809
8. Dahl J.S., Dahl C.E., and Levine R.P. Role of lipid fatty acyl composition and membrane fluidity in the resistance of Acholeplasma laidlawii to complement-mediated killing. J. Immunol. 123 (1979) 104-108
9. Dahl M.V., Falk R.J., Carpenter R., and Michael A.F. Deposition of the membrane attack complex in bullous pemphigoid. J. Invest. Dermatol. 82 (1984) 132-136
10. Dalmasso A.P., and Benson B.A. Lesions of different functional size produced by human and guinea pig complement in sheep red blood cell membranes. J. Immunol. 127 (1981) 2214-2218
11. Deckert M., Kubar J., and Bernard A. CD58 and CD59 molecules exhibit potentializing effects in T cell adhesion and activation. J. Immunol. 148 (1992) 672-677
12. Deppisch R., Schmitt V., Bommer J., Hänsch G.M., Ritz E., and Rauterberg E.W. Fluid phase generation of terminal complement complex as a novel index of biocompatibility. Kidney Int. 37 (1990) 696-706
13. DiScipio R.G., Chakvarati D.N., Müller-Eberhard H.J., and Fey G.H. The structure of human complement C7 and C5b-7 complex. J. Biol. Chem. 263 (1988) 549-560
14. DiScipio R.G., Smith C.A., Müller-Eberhard H.J., and Hugli T.E. The activation of human complement component C5 by a fluid phase C5 convertase. J. Biol. Chem. 258 (1983) 10629-10636
15. Engel A.G., and Bieseker G. Complement activation in muscle fiber necrosis: Demonstration of the membrane attack complex of complement in necrotic fibers. Ann. Neurol. 12 (1982) 289-296
16. Falk R.J., Dalmasso A.P., Kim Y., Tsai C., Scheinmann J.I., Gewunz H., and Michael A.F. Neoantigen of the polymerized ninth component of complement. Characterization of a monoclonal antibody and immunohistochemical localization in renal disease. J. Clin. Invest. 72 (1983) 560-573
17. Frank M.M., and Fries L.F. Complement. In: Paul W.E. (Ed). Fundamental Immunology. 2nd Ed. (1989), Raven Press, Oxford 679-701
18. French L., Chonn A., Ducrest D., Baumann B., Belin D., Wohlwend A., Kiss J.Z., Sappino A.P., Tschopp J., and Schifferli J.A. Murine clusterin: Molecular cloning and mRNA localization during embriogenesis. J. Cell. Biol. 122 (1993) 1119-1130
19. 86Rb and hemoglobin release. J. Immunol. 124 (1980) 1905-1910
20. Haeflinger J.A., Jenne D., Stanley K.K., and Tschopp J. Structural homology of human complement component C8γ and plasma protein HC: Identity of the cysteine bond pattern. Biochim. Biophys. Acta 149 (1987) 750-754
21. Haeflinger J.A., Tschopp J., Vial N., and Jenne D.E. Complete primary structure and functional characterization of the sixth component of the human complement system. J. Biol. Chem. 264 (1989) 18041-18051
22. Hahn W.C., Menu E., Bothwell A.L.M., Sims P.J., and Bierer B.E. Overlapping but non-identical binding sites on CD2 for CD58 and a second ligand CD59. Science 256 (1992) 1805-1807
23. Halstensen T.S., Mollnes T.E., Garred P., Fausa O., and Brandtzaeg P. Epithelial deposition of immunoglobulin G1 and activated complement (C3b and terminal complement complex) in ulcerative colitis. Gastroenterology 98 (1990) 1261-1271
24. Hamilton K.K., Zhao J., and Sims P.J. Interaction between apolipoproteins AI and AII and the membrane attack complex of complement. J. Biol. Chem. 268 (1993) 3632-3638
25. Hänsch G.M. The complement attack phase: Control of lysis and non-lethal effects of C5b-9. Immunopharmacology 24 (1992) 107-117
26. Hänsch G.M., Weller P.F., and Nicholson-Weller A. Release of C8 binding protein (C8bp) from the cell membrane by phosphatidylinositol-specific phospholipase C. Blood 72 (1988) 1089-1092
27. Hänsch G.M., Seitz M., and Betz M. Effect of the late complement components C5b-9 on human monocytes; release of prostanoids, oxygen radicals and of a factor inducing cell proliferation. Int. Arch. Allergy. Appl. Immunol. 82 (1987) 317-320
28. Haviland D.L., Haviland J.C., Fleischer D.T., and Wetsel R.A. Structure of the murine fifth complement component (C5) gene. J. Biol. Chem. 266 (1991) 11818-11825
29. Hinglais N., Kazatchkine M.D., Bhakdi S., Appay M.D., Mandet C., Grossetete J., and Bariety J. Immunohistochemical study of the C5b-9 complex of complement in human kidneys. Kidney Int. 30 (1986) 399-410
30. Hobart M.D., Fernie B., and DiScipio R.G. Structure of the human C6 gene. Biochemistry 32 (1993) 6198-6205
31. Hu V.W., Esser A.F., Podack E.R., and Wisnieski B.J. The membrane attack mechanism of complement photolabelling reveals insertion of terminal proteins into target membranes. J. Immunol. 127 (1981) 380-386
32. Iida K., Whitlow M.B., and Nussenzweig V. Membrane vesiculation protects erythrocytes from destruction by complement. J. Immunol. 147 (1991) 2638-2642
33. Imagawa D.K., Osifchin N.E., Paznekas W.A., Shin M.L., and Mayer M.M. Consequence of cell membrane attack by complement: Release of arachidonate and formation of inflammatory derivatives. Proc. Natl. Acad. Sci. USA 80 (1983) 6647-6651
34. Ishida B., Wisnieski B.J., Lavine C.H., and Esser A.F. Photolabelling of a hydrophobic domain of the ninth component of human complement. J. Biol. Chem. 257 (1982) 10551-10553
35. Jenne D.E., and Tschopp J. Molecular structure and functional characterization of a human complement cytolysis inhibitor found in blood and seminal plasma: Identity to sulfated glycoprotein 2, a constituent of rat testis. Proc. Natl. Acad. Sci. USA 86 (1989) 7123-7127
36. Joiner K.A. Complement evasion by bacteria and parasites. Ann. Rev. Microbiol. 42 (1988) 201-230
37. Kawana S., Shen G.H., Kobayashi Y., and Nijkiyana S. Membrane attack of complement in Henoch-Schönlein purpura skin and nephritis. Arch. Dermatol. Res. 292 (1990) 183-187
38. Kiessel J.T., Mendeli J.R., and Rammohan K.W. Microvascular deposition of complement membrane attack complex in dermatomyositis. N. Engl. J. Med. 314 (1986) 329-334
39. 2+ on the lytic process. J. Immunol. 138 (1987) 1530-1536
40. Koski C.L., Sanders M.E., Swoveland P.T., Lawley T.J., Shin M.L., Frank M.M., and Joiner K.A. Activation of terminal components of complement in patients with Guillain-Barré syndrome and other demyelinating neuropathies. J. Clin. Invest. 80 (1987) 1492-1497
41. Koski C.L., Ramm E.L., Hammer C.H., Mayer M.M., and Shin M.L. Cytolysis of nucleated cells by complement: Cell death displays multi-hit characteristics. Proc. Natl. Acad. Sci. USA 80 (1983) 3816-3820
42. Laine R.O., and Esser A.F. Detection of refolding conformers of complement protein C9 during insertion into membranes. Nature 341 (1989) 63-65
43. (Abstr.). Lang T., and Shin M. Changes in levels of muscle specific mRNAs in a myotube cell line after treatment with sublytic doses of C5b-9. Complement. Inflamm. 8 (1991) 179
44. Lovett D.H., Hänsch G.M., Goppelt M., Resch K., and Gemsa D. Activation of glomerular mesangeal cells by terminal membrane attack of complement. J. Immunol. 138 (1987) 2473-2480
45. Marazziti D., Eggertsen G., Fey G., and Stanley K.K. Relationships between the gene and protein structure in human complement component C9. Biochemistry 27 (1988) 6529-6534
46. Mayer M.M., Michaels D.W., Ramm L.E., Whitlow M.B., Willoughby J.B., and Shin M.L. Membrane damage by complement. CRC Crit. Rev. Immunol. 7 (1981) 133-165
47. Mayer M.M. Development of one-hit theory of immune lysis. In: Heidelberg M., and Plescia T. (Eds). Immunochemical Approaches to Problems in Biochemistry (1961), Rutgers University Press, New York 279-288
48. Meri S., Waldmann H., and Lachmann P.J. Distribution of protectin (CD59) a complement membrane attack inhibitor, in normal human tissue. Lab. Invest. 65 (1991) 532-537
49. Miyata T., Takeda J., Iida Y., Yamada N., Inoue N., Takahashi M., Maeda K., Kitani T., and Kinoshita T. The cloning of PIG-A, a component in the early step of GPI-anchor biosynthesis. Science 259 (1993) 1318-1320
50. Mollness T.E., and Paus A. Complement activation in synovial fluid and tissue from patients with juvenile rheumatoid arthritis. Arthritis Rheum. 29 (1986) 1359-1365
51. Morgan B.P., Dankert J.R., and Esser A.F. Recovery of human neutrophils from complement attack: Removal of membrane attack complex by endocytosis and exocytosis. J. Immunol. 138 (1987) 246-253
52. Morgan B.P., and Campbell A.K. A recovery of human polymorphonuclear leukocytes from sublytic complement attack is mediated by changes in intracellular free calcium. Biochem. J. 231 (1985) 205-208
53. Murphy B.F., Saunders J.R., O'Bryan M.K., Kirsbaum L., Walker I.D., and d'Apice A.J.F. Sp 40,40 is an inhibitor of C5b-6 initiated hemolysis. Int. Immunol. 1 (1989) 551-556
54. Müller-Eberhard H.J. Molecular organization and function of the complement system. Ann. Rev. Biochem. 57 (1988) 321-347
55. Niculescu F., Rus H.G., and Shin M.L. Receptor-independent activation of guanine nucleotide-binding proteins by terminal complement complexes. J. Biol. Chem. 269 (1994) 4417-4423
56. Niculescu F., Rus H.G., Shin S., Lang T., and Shin M.L. Generation of diacylglycerol and ceramide during homologous complement activation. J. Immunol. 150 (1993) 214-224
57. Niculescu F., Rus H.G., Retegan M., and Vlaicu R. Persistent complement activation on tumor cells in breast cancer. Amer. J. Pathol. 140 (1992) 1039-1043
58. Niculescu F., Rus H.G., Porutiu D., Ghiurca V., and Vlaicu R. Immuno-electron microscopic localization of S-protein/vitronectin in human atherosclerotic wall. Atherosclerosis 78 (1989) 197-203
59. Niculescu F., Rus H.G., and Vlaicu R. Immunohistochemical localization of C5b-9, S-protein, C3d and apolipoprotein B in human arterial tissues with atherosclerosis. Atherosclerosis 65 (1987) 1-11
60. Niculescu F., Rus H.G., Cristea A., and Vlaicu R. Localization of the terminal C5b-9 complement complex in aortic atherosclerotic wall. Immunol. Lett. 10 (1985) 109-114
61. Ninomiya H., and Sims P.J. The human complement regulatory protein CD59 binds to the α-chain of C8 and the "b" domain of C9. J. Biol. Chem. 267 (1992) 13675-13680
62. Pangburn M.K. Initiation and activation of the alternative pathway of complement. In: Podack E.R. (Ed). Cytotoxic Lymphocytes and Complement: Effectors of the Immune System (1988), CRC Press, New Brunswick, NJ 41-56
63. Papadimitriou J.C., Ramm L.E., Drachenberg C.B., Trump B.F., and Shin M.L. Quantitative analysis of adenine nucleotides during the prelytic phase of cell death mediated by C5b-9. J. Immunol. 147 (1991) 212-217
64. Podack E.R. Assembly and structure of membrane attack complex (MAC) of complement. In: Podack E.R. (Ed). Cytolytic Lymphocyte and Complement: Effectors of the Immune System (1988), CRC Press, Boca Raton, FL 174-184
65. Podack E.R., and Tschopp J. Polymerization of the ninth component of complement (C9): Formation of poly C9 with a tubular structure resembling the membrane attack complex of complement. Proc. Natl. Acad. Sci. USA 79 (1982) 574-578
66. Podack E.R., and Müller-Eberhard H.J. Binding of desoxycholate, phosphatidylcholine vesicles, lipoprotein and of the S-protein to complexes of terminal complement proteins. J. Immunol. 121 (1978) 1025-1030
67. Polihronis M., Machet D., Seunders J., O'Bryan M., McRae J., and Murphy B. Immunohistological detection of C5b-9 complement complexes in normal and pathological human livers. Pathology 25 (1993) 20-23
68. Preissner K.T. Structure and biological role of vitronectin. Ann. Rev. Cell Biol. 7 (1991) 275-310
69. Ramm L.E., Whitlow M.B., and Mayer M.M. The relationship between channel size and the number of C9 molecules in the C5b-9 complex. J. Immunol. 134 (1985) 2594-2599
70. Ramm L.E., Michaels D.W., Whitlow M.B., and Mayer M.M. On the heterogenity and molecular composition of the transmembrane channels produced by complement. In: August T. (Ed). Biological Response Mediators and Modulators (1983), Academic Press, Boca Raton, FL 117-132
71. Ramm L.E., Withlow M.B., and Mayer M.M. Size and transmembrane channels produced by complement proteins C5b-8. J. Immunol. 122 (1982) 1143-1146
72. Rao A.G., Howard O.M.Z., Ng S.C., Whitehead A.S., Colten H.R., and Sodetz J.M. Complementary DNA and derived aminoacid sequence of the α subunit of human complement C8: Evidence for the existence of a separate α subunit messenger RNA. Biochemistry 26 (1987) 3556-3564
73. Rus H.G., Niculescu F., and Shin M.L. Sublytic complement attack induces cell cycle in oligodendrocytes. S phase induction is dependent on c-jun activation. J. Immunol. 156 (1996) 4892-4900
74. Rus H.G., Niculescu F., and Vlaicu R. Presence of C5b-9 complement complex and S-protein in human myocardial areas with necrosis and sclerosis. Immunol. Lett. 16 (1987) 15-20
75. Rus H.G., Niculescu F., Nanulescu M., Cristea A., and Florescu P. Immunohistochemical detection of the terminal C5b-9 complement complex in children with glomerular disease. Clin. Exp. Immunol. 65 (1986) 66-72
76. Salama A., Hugo F., Heinrich D., Höge R., Müller R., Kiefel V., Müller-Eckhart C., and Bhakdi S. Deposition of terminal C5b-9 complement complexes on erythrocytes and leukocytes during cardiopulmonary bypass. N. Eng. J. Med. 318 (1988) 408-414
77. Sanders M.E., Koski C.L., Robbins D., Shin M.L., Frank M.M., and Joiner K.A. Activated terminal complement in cerebrospinal fluid in Guillain-Barré syndrome and multiple sclerosis. J. Immunol. 136 (1986) 4456-4459
78. Sanders M.E., Kopicky J.A., Wigley F.M., Shin M.L., Frank M.M., and Joiner K.A. Membrane attack complex of complement in rheumatoid synovial tissue demonstrated by immunofluorescent microscopy. J. Rheumatol. 13 (1986) 1028-1034
79. Schäfer H.J., Mathey D., Hugo F., and Bhakdi S. Deposition of the terminal C5b-9 complement complex in infarcted areas of human myocardium. J. Immunol. 137 (1986) 1945-1949
80. Schieren G., Janssen O., and Hänsch G.M. Enhanced expression of the complement regulatory factor C8 binding protein (C8bp) on U937 cells after stimulation with interleukin-1β, endotoxin, γ-interferon or phorbol ester. J. Immunol. 148 (1992) 3183-3188
81. Schlager S.I., and Ohanian S.H. Tumor cell lipid composition and sensitivity to humoral immune killing. II. Influence of plasma membrane and intracellular lipid and fatty acid content. J. Immunol. 125 (1980) 508-517
82. Schönermark M., Deppisch R., Riedasch G., Rother K., and Hänsch G.M. Induction of mediators release from human glomerular mesangial cells by the terminal complement components C5b-9. Int. Arch. Allergy. Appl. Immunol. 96 (1991) 331-337
83. Schönermark S., Rauterberg E.W., Shin M.L., Löke S., Roelcke D., and Hänsch G.M. Homologous species restriction in lysis of human erythrocytes: A membrane derived protein with C8-binding functions as an inhibitor. J. Immunol. 136 (1986) 1772-1776
84. Seeger W., Suttorp N., Hellwig A., and Bhakdi S. Noncytolytic terminal complement complexes may serve as calcium gates to elicit leukoterine B4 generation in human polymorphonuclear leukocytes. J. Immunol. 137 (1986) 1286-1293
85. Shin M.L., and Carney D.F. Cytotoxic action and other metabolic consequences of terminal complement proteins. Prog. Allergy 40 (1988) 44-81
86. Shin M.L., Paznekas W.A., and Mayer M.M. On the mechanism of membrane damage by complement: The effect of length and saturation of the acyl chains in the liposomal bilayers and the effect of cholesterol concentration in sheep erythrocytes and liposomal membranes. J. Immunol. 120 (1978) 1996-2002
87. Shin M.L., Paznekas W.A., Abramovitz A.S., and Mayer M.M. On the mechanism of membrane damage by complement: Exposure of hydrophobic sites on activated complement proteins. J. Immunol. 119 (1977) 1358-1364
88. Shirazi Y., Rus H.G., Macklin W.B., and Shin M.L. Enhanced degradation of messenger RNA encoding myelin proteins by terminal complement complexes in oligodendrocytes. J. Immunol. 150 (1993) 4581-4590
89. Shirazi Y., Imagawa D.K., and Shin M.L. Release of leukotriene B4 from sublethally injured oligodendrocytes by terminal complement complexes. J. Neurochem. 48 (1987) 271-278
90. Sodetz J.M. Structure and function of C8 in the membrane attack sequence of complement. In: Podack E.R. (Ed). Cytotoxic Effector Mechanisms (1988), Springer Verlag, San Diego 19-31
91. Stanley K.K. The molecular mechanisms of complement C9. Insertion and polymerization in biological membranes. Curr. Topics. Microbiol. Immunol. 140 (1988) 49-65
92. Tschopp J., Chonn A., Herting S., and French L.E. Clusterin, the human apolipoprotein and complement inhibitor, binds to complement C7, C8β and the b domain of C9. J. Immunol. 151 (1993) 2159-2165
93. Tschopp J., Podack E.R., and Müller-Eberhard H.J. The membrane attack of complement: C5b-8 as accelerator of C9 polymerization. J. Immunol. 134 (1985) 10551-10553
94. Vanguri P., and Shin M.L. Hydrolysis of myelin basic protein in human myelin by terminal complement complexes. J. Biol. Chem. 263 (1988) 7228-7234
95. Walport H.J., and Lachmann P.J. Complement. In: Lachmann P.J., Peters K., Rosen F.S., and Walport H.J. (Eds). Clinical Aspects of Immunology (1993), Blackwell Science Publishers, Berlin 347-375
96. Wetsel R.A., Lemons R.S., LeBeau M.M., Barnum S., Noack D., and Tack B.F. Molecular analysis of human complement component C5: Localization of the structural gene to chromosome 9. Biochemistry 27 (1988) 1474-1482
97. Wetsel R.A., Ogata R.T., and Tack B.F. Primary structure of the fifth component of murine complement. Biochemistry 26 (1987) 737-743
98. Whitlow M., Iida K., Marshall P., Silber R., and Nussenzweig V. Cells lacking glycan phosphatidylinositol-linked protein have impaired ability to vesiculate. Blood 81 (1993) 510-516
99. Whitlow M.B., Ramm L.E., and Mayer M.M. Penetration of C8 and C9 in the C5b-9 complex across the erythrocyte membrane into the cytoplasmic space. J. Biol. Chem. 260 (1985) 998-1005
100. Wiedmer T., and Sims P.J. Participation of protein kinases in complement C5b-9 induced shedding of platelet plasma membrane vesicles. Blood 78 (1991) 2880-2886
101. 2+-initiated activation of cellular protein kinases. J. Biol. Chem. 262 (1987) 13674-13682
102. Yamashina M., Ueda E., Kinoshita T., Takami T., Ojima A., Ono H., Tanaka H., Kondo N., Orri T., Okada N., Okada H., Inoue K., and Kitani T. Inherited complete deficiency of 20-kilodalton homologous restriction factor (CD59) as a cause of paroxysmal nocturnal hemoglobinuria. N. Engl. J. Med. 323 (1990) 1184-1189
103. Young D.E., Cohn Z.A., and Podack E.R. The ninth component of complement and the pore forming protein perforin (perforin 1) from cytotoxic T cell: Structural, immunological and functional studies. Science 233 (1986) 184-190
104. Zalman L., Wood M., and Müller-Eberhard H.J. Isolation of a human erythrocyte membrane capable of inhibiting expression of homologous complement transmembrane channels. Proc. Natl. Acad. Sci. USA 83 (1986) 6975-6979